Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 result for clascoterone

  1. Clascoterone for treating acne vulgaris in people 12 years and over (terminated appraisal) (TA1105)

    NICE is unable to make a recommendation on clascoterone (Winlevi) for treating acne vulgaris in people 12 years and over. This is because the company did not provide an evidence submission.

    Sections for TA1105